Celltrion
068270.KS
#748
Rank
C$37.64 B
Marketcap
$181.76
Share price
0.72%
Change (1 day)
10.05%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : C$2.23 Billion

According to Celltrion 's latest financial reports the company's total debt is C$2.23 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31C$0.85 B6.95%
2021-12-31C$0.79 B-12.28%
2020-12-31C$0.90 B62.44%
2019-12-31C$0.55 B-11.24%
2018-12-31C$0.63 B-16.6%
2017-12-31C$0.75 B-0.14%
2016-12-31C$0.75 B-19.41%
2015-12-31C$0.93 B4.85%
2014-12-31C$0.89 B18.38%
2013-12-31C$0.75 B31.87%
2012-12-31C$0.57 B56.89%
2011-12-31C$0.36 B49.96%
2010-12-31C$0.24 B7.31%
2009-12-31C$0.22 B0.11%
2008-12-31C$0.22 B673.22%
2007-12-31C$29.36 M